RU2197491C2 - Конденсированное производное тиофена, производное бензотиофена, производное тиенобензоксазепинона, фармацевтическое средство и фармацевтическая композиция - Google Patents

Конденсированное производное тиофена, производное бензотиофена, производное тиенобензоксазепинона, фармацевтическое средство и фармацевтическая композиция Download PDF

Info

Publication number
RU2197491C2
RU2197491C2 RU2000108433/04A RU2000108433A RU2197491C2 RU 2197491 C2 RU2197491 C2 RU 2197491C2 RU 2000108433/04 A RU2000108433/04 A RU 2000108433/04A RU 2000108433 A RU2000108433 A RU 2000108433A RU 2197491 C2 RU2197491 C2 RU 2197491C2
Authority
RU
Russia
Prior art keywords
benzothieno
benzodiazepine
formula
methylpiperazin
methyl
Prior art date
Application number
RU2000108433/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2000108433A (ru
Inventor
Кодзи СЕЙО (JP)
Кодзи СЕЙО
Хироси ТАНАКА (JP)
Хироси ТАНАКА
Тосийуки КОХАРА (JP)
Тосийуки КОХАРА
Кендзи ХАСИМОТО (JP)
Кендзи Хасимото
Масатаке ФУДЗИМУРА (JP)
Масатаке ФУДЗИМУРА
Хидеки ХОРИУТИ (JP)
Хидеки ХОРИУТИ
Хироси ЙАСУМАТСУ (JP)
Хироси ЙАСУМАТСУ
Кореити КИМУРА (JP)
Кореити КИМУРА
Original Assignee
Мицубиси Фарма Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27322564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2197491(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Мицубиси Фарма Корпорейшн filed Critical Мицубиси Фарма Корпорейшн
Publication of RU2000108433A publication Critical patent/RU2000108433A/ru
Application granted granted Critical
Publication of RU2197491C2 publication Critical patent/RU2197491C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2000108433/04A 1997-09-02 1998-08-31 Конденсированное производное тиофена, производное бензотиофена, производное тиенобензоксазепинона, фармацевтическое средство и фармацевтическая композиция RU2197491C2 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP9/236700 1997-09-02
JP23670097 1997-09-02
JP27777197 1997-10-09
JP9/277771 1997-10-09
JP10/165725 1998-06-12
JP16572598 1998-06-12

Publications (2)

Publication Number Publication Date
RU2000108433A RU2000108433A (ru) 2002-03-20
RU2197491C2 true RU2197491C2 (ru) 2003-01-27

Family

ID=27322564

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000108433/04A RU2197491C2 (ru) 1997-09-02 1998-08-31 Конденсированное производное тиофена, производное бензотиофена, производное тиенобензоксазепинона, фармацевтическое средство и фармацевтическая композиция

Country Status (16)

Country Link
US (2) US6271225B1 (cg-RX-API-DMAC10.html)
EP (1) EP1016664B1 (cg-RX-API-DMAC10.html)
JP (2) JP3156933B2 (cg-RX-API-DMAC10.html)
KR (1) KR20010021989A (cg-RX-API-DMAC10.html)
CN (1) CN1268949A (cg-RX-API-DMAC10.html)
AT (1) ATE244245T1 (cg-RX-API-DMAC10.html)
AU (1) AU739385B2 (cg-RX-API-DMAC10.html)
BR (1) BR9814042A (cg-RX-API-DMAC10.html)
CA (1) CA2302409A1 (cg-RX-API-DMAC10.html)
DE (1) DE69816102D1 (cg-RX-API-DMAC10.html)
HU (1) HUP0003718A3 (cg-RX-API-DMAC10.html)
IL (1) IL134812A0 (cg-RX-API-DMAC10.html)
NO (1) NO20001049L (cg-RX-API-DMAC10.html)
NZ (1) NZ503484A (cg-RX-API-DMAC10.html)
RU (1) RU2197491C2 (cg-RX-API-DMAC10.html)
WO (1) WO1999011647A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
CA2536107A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US12365696B2 (en) 2019-05-10 2025-07-22 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (FAK) inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454436A1 (en) * 1990-04-25 1991-10-30 Lilly Industries Limited Pharmaceutical compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454436A1 (en) * 1990-04-25 1991-10-30 Lilly Industries Limited Pharmaceutical compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы

Also Published As

Publication number Publication date
US6271225B1 (en) 2001-08-07
DE69816102D1 (de) 2003-08-07
NZ503484A (en) 2001-10-26
ATE244245T1 (de) 2003-07-15
IL134812A0 (en) 2001-04-30
NO20001049L (no) 2000-04-03
HUP0003718A3 (en) 2002-11-28
NO20001049D0 (no) 2000-03-01
JP3156933B2 (ja) 2001-04-16
KR20010021989A (ko) 2001-03-15
EP1016664A1 (en) 2000-07-05
HUP0003718A2 (hu) 2001-09-28
AU739385B2 (en) 2001-10-11
US20020042411A1 (en) 2002-04-11
EP1016664B1 (en) 2003-07-02
CN1268949A (zh) 2000-10-04
CA2302409A1 (en) 1999-03-11
WO1999011647A1 (en) 1999-03-11
JP2001072684A (ja) 2001-03-21
AU8889098A (en) 1999-03-22
US6455521B1 (en) 2002-09-24
EP1016664A4 (en) 2001-01-24
BR9814042A (pt) 2000-10-03
JP4354106B2 (ja) 2009-10-28

Similar Documents

Publication Publication Date Title
US6455521B1 (en) Condensed thiophene compounds and pharmaceutical use thereof
JPWO1999011647A1 (ja) 縮合チオフェン化合物およびその医薬用途
DE60119719T2 (de) Neue aza-indolyl derivate
CN112062730B (zh) 作为gpr139的调节剂的4-氧代-3,4-二氢-1,2,3-苯并三嗪类
JPH09291034A (ja) 縮合ピリジン化合物およびその医薬としての用途
US20100190772A1 (en) Substituted Azepine Derivatives As Serotonin Receptor Modulators
CN102245612A (zh) 新型三环衍生物或其药物可接受的盐、其制备方法和含有它们的药物组合物
WO2007129111A1 (en) Diazepine derivatives as 5-ht2a antagonists
JP4065604B2 (ja) 新規なクロメン化合物、それらの製造方法及びそれらを含む医薬組成物
WO1997003986A1 (en) Fused triazole compounds
CS236753B2 (en) Processing of thieno (1,5) benzodiazepine derivatives
TWI495640B (zh) 苯並氮呯化合物
AU2005333518A1 (en) Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
DE60005685T2 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen
CN101243046A (zh) 酰基胍衍生物或其盐
WO2001014384A1 (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents
HK1029340A (en) Fused thiophene compounds and medicinal use thereof
CZ2000757A3 (cs) Kondenzované thiofenové sloučeniny a jejich farmaceutické použití
MXPA00002221A (en) Fused thiophene compounds and medicinal use thereof
ES2260636T3 (es) 1-oxa-3-azadibenzoazulenos utilizados como inhibidores de la produccion del factor de necrosis tumoral e intermediarios destinados a la produccion de estos ultimos.
WO2025067486A1 (zh) 一类喹啉酮化合物、其制备方法和用途
JPWO1997003986A1 (ja) 縮合トリアゾール化合物
JPWO1997032848A1 (ja) 縮合へテロ環化合物およびその医薬用途
JPWO1996025416A1 (ja) チオフェン化合物およびその医薬用途

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20030901